Business
Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study
(TheNewswire) Calgary, Alberta – September 18, 2023.  Ocumetics Technology ...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, Alberta\n \n \n – September 18, 2023.  Ocumetics Technology Corp.\n(“\n \n \n Ocumetics\n \n \n ”) (\n \n \n TSXV:OTC) (OTC:OTCFF) (FRA:2QBO),\na pioneer in\n \n \n in the field of ophthalmic\ninnovation, proudly confirms a remarkable achievement in the\noptimization of its vision correction technology - the Ocumetics\nAccommodating Lens. Through rigorous research and development efforts\nover the past two years, Ocumetics has modified its lens design five\ntimes, ultimately arriving at its groundbreaking final lens\nconfiguration version 10.5. Lens version 10.5 has been tested in vitro\nand in an animal model, and will be used in Ocumetics’ upcoming\nhuman clinical trials.\n \n \n \n \n This achievement is a testament to Ocumetics'\npersistence and unwavering commitment to delivering the most advanced\nand efficient vision correction solution possible.  The optimization\nprocess has been conducted with a meticulous focus on quality and\nperformance, ensuring that the upcoming first-in-human study,\nanticipated to commence in Q1 2024 in the Dominican Republic, will\nbenefit from the most advanced technology available.\n \n \n \n \n Dr. Garth Webb, Founder and Chief Scientific Officer of\nOcumetics, emphasized the importance of this achievement, stating,\n\"Entering the first-in-human study with an optimized lens design\nis paramount to our mission.  We have relentlessly pursued excellence\nto ensure that our technology offers the best possible vision\ncorrection experience for patients.\"\n \n \n \n \n Dean Burns, President and CEO of Ocumetics, highlighted\nthe company's innovative culture, saying, \"Our success in\noptimizing the lens design underscores our dedication to understanding\nthe needs of patients and listening to our valued investigators and\nadvisors.  This iterative process reflects our commitment to\ndelivering on our promise of enhanced vision.\"\n \n \n \n \n Dean Burns adds, “Ocumetics remains at the forefront\nof vision correction technology research and is dedicated to\ntransforming the lives of individuals worldwide.  Th...